$CYDY News Article - CytoDyn Receives Clearance from Brazil's FDA (ANVISA) to Commence a Pivotal Phase 3 Trial in Critically Ill COVID-19 Patients with IV Administration of Four Doses (700mg/week)
https://marketwirenews.com/news-releases/cyto...86391.html